2,4-PYRIMIDINEDIAMINE COMPOUNDS FOR USE IN THE TREATMENT OR PREVENTION OF AUTOIMMUNE DISEASES

WIPO Patent Application WO2005016893

A3

The present invention provides methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds, as well as methods of treating, preventing or ameliorating symptoms associated with such diseases. Specific examples of autoimmune diseases that can be treated or prevented with the compounds include rheumatoid arthritis and/or its associated symptoms, systemic lups erythematosis and/or its associated symptoms and multiple sclerosis and/or its associated symptoms.

RAJINDER SINGH (US)
ANKUSH ARGADE (US)
LI HUI (US)
BHAMIDIPATI SOMASEKHAR (US)
CARROLL DAVID (US)
SYLVAIN CATHERINE (US)
CLOUGH JEFFREY (US)
KEIM HOLGER (US)

PCT/US2004/024716

June 09, 2005

July 30, 2004

Click for automatic bibliography generation  

RIGEL PHARMACEUTICALS INC (US)
RAJINDER SINGH (US)
ANKUSH ARGADE (US)
LI HUI (US)
BHAMIDIPATI SOMASEKHAR (US)
CARROLL DAVID (US)
SYLVAIN CATHERINE (US)
CLOUGH JEFFREY (US)
KEIM HOLGER (US)

A61K31/505; A61K31/506; A61K31/538; A61K31/5415; A61K31/542; A61P37/00; C07D403/12; C07D405/12; C07D405/14; C07D413/02; C07D413/12; C07D413/14; C07D417/02; C07D417/12; C07D417/14; C07D498/02; C07D498/04; C07D498/06; (IPC1-7): C07D413/14; C07D413/12; C07D417/12; A61K31/505; A61P37/00

WO2002096888A1	2002-12-05
WO2000039101A1	2000-07-06
WO2003040141A1	2003-05-15
WO2003026664A1	2003-04-03
WO2003055489A1	2003-07-10
WO2003030909A1	2003-04-17
WO2003063794A2	2003-08-07
WO2004014382A1	2004-02-19

View/Download PDF      PDF Help

Previous Patent: GABANERGIC MODULATORS

Next Patent: NOVEL COMPOUND OF 6-METHYL-3-PHENETHYL-3,4-DIHYDRO-1H-QUINAZOLINE-2-THINONE, ITS PREPARATION AND A D...